Click Here to Go Directly to the Story
Register/Subscribe
Home




U.S. EDITION
Full Table of Contents
 Cover Story
Up Front
Readers Report
Corrections & Clarifications
Books
Technology & You
Economic Viewpoint
Economic Trends
Industry Insider
Business Outlook

News: Analysis & Commentary
In Business This Week
Washington Outlook
International Business
International Outlook
Government
Information Technology
Social Issues
The Corporation
People

Sports Business
Finance
Science & Technology
Developments to Watch
BusinessWeek Investor
BusinessWeek Lifestyle
The Barker Portfolio
Inside Wall Street
Figures of the Week
Editorials


E.BIZ SUPPLEMENT March 18 Table of Contents

INTERNATIONAL EDITIONS
International -- Readers Report
International -- Asian Business
International -- European Business
International -- Finance
International -- Int'l Figures of the Week


MARCH 18, 2002

Corrections & Clarifications

  STORY TOOLS
Printer-Friendly Version
E-Mail This Story

On This Page
"New drugs: Why so many delays?" (Science & Technology, Mar. 11, 2002)

"New drugs: Why so many delays?" (Science & Technology, Mar. 11, 2002)

 "New drugs: Why so many delays?" (Science & Technology, Mar. 11) said Chiron Corp.'s HIV blood test, Procleix, was pending Food & Drug Administration approval. The drug was approved on Feb. 28, a year after the application was filed and a day after BusinessWeek's issue went to press.



Back to Top


[an error occurred while processing this directive]


Copyright 2002, Bloomberg L.P.
Terms of Use | Privacy Policy

Media Kit | Special Sections | MarketPlace | Knowledge Centers
Bloomberg L.P.